Sponsor:
Wayne State University
Code:
NCT05091138
Conditions
Post-operative Pain, Acute
Opioid Use
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Adding Magnesium as an adjuvant to Bupivacaine in the adductor canal block (ACB) for same-day discharge total knee arthroplasty
Adding Buprenorphine as an adjuvant to Bupivacaine in the adductor canal block (ACB) for same-day discharge total knee arthroplasty
Brief summary:
Conditions
Post-operative Pain, Acute
Opioid Use
Study ID
NCT05091138
Start date
Oct 12, 2021
Status verified date
Oct, 2021
Completion date
Oct 1, 2022
Anticipated
Primary completion date
Oct 1, 2022
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
active comparator: Mg and Bupivacaine
active comparator: Buprenorphine and Bupivacaine
Interventions
Adding Magnesium as an adjuvant to Bupivacaine in the adductor canal block (ACB) for same-day discharge total knee arthroplasty
Adding Buprenorphine as an adjuvant to Bupivacaine in the adductor canal block (ACB) for same-day discharge total knee arthroplasty
Primary outcome measure
Central contacts
Locations
St. Joseph Mercy Oakland Hospital
Recruiting
Pontiac, Michigan, United States, 48341
Contacts
Sponsor
Wayne State University
Last update posted
Oct 25, 2021
Last verified
Oct, 2021
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Wayne State University on 2021-10-25.